Results 81 to 90 of about 2,212 (184)

Interleukin-1 blockers for the treatment of recurrent pericarditis: pathophysiology, patient reported outcomes and perspectives

open access: yes, 2023
Recurrent pericarditis (RP) is the most troublesome complication of acute pericarditis reflecting an unresolving inflammation of the pericardial sac around the heart and associated with significant morbidity. Recent studies have shown interleukin-1 (IL-1)
Aldo Bonaventura   +15 more
core   +1 more source

Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives

open access: yesJournal of Functional Biomaterials
This review aimed at searching literature for data regarding the inflammasomes’ involvement in the pathogenesis of oral diseases (mainly periodontitis) and general pathologies, including approaches to control inflammasome-related pathogenic mechanisms ...
Norina Vinţeler   +7 more
doaj   +1 more source

Alveolar IL1β+ neutrophils: Emerging biomarkers and therapeutic targets in CARDS progression

open access: yes
Clinical and Translational Discovery, Volume 5, Issue 5, October 2025.
Lu Jia, Ying Tang, Jianfeng Xie
wiley   +1 more source

IL-1 Inhibition and Vascular Function in CKD

open access: yes, 2016
Vascular endothelial dysfunction and increased arterial stiffness contribute to increased cardiovascular risk in patients with CKD who exhibit chronic systemic inflammation.
Smits, G.   +21 more
core   +1 more source

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology

open access: yesPediatric Rheumatology Online Journal, 2012
Background The management of background corticosteroid therapy in rheumatology clinical trials poses a major challenge. We describe the consensus methodology used to design an algorithm to standardize changes in corticosteroid dosing during the ...
Ilowite Norman T   +23 more
doaj   +1 more source

Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome

open access: yesOpen Access Rheumatology: Research and Reviews, 2011
Pierre QuartierUnité d'Immunologie-Hématologie et Rhumatologie pédiatriques, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, FranceAbstract: Cryopyrin-associated ...
Pierre Quartier
doaj  

Contemporary Recurrent Pericarditis Management – Real-World Evidence of Limited Cardiac Magnetic Resonance Imaging Prior to Initiating Rilonacept [PDF]

open access: yes
Contemporary Recurrent Pericarditis Management – Real-World Evidence of Limited Cardiac Magnetic Resonance Imaging Prior to Initiating Rilonacept  Brittany Weber, MD, PhD1, Paul C. Cremer, MD2, Michael S.
Curtis, Allison   +9 more
core  

Cryopyrin-Associated Periodic Syndromes (CAPS): Pathogenesis, Clinical Manifestations, and IL-1-Targeted Therapeutic Strategies

open access: yesJournal of Education, Health and Sport
Cryopyrin-associated periodic syndromes (CAPS) are a group of rare, genetically determined autoinflammatory diseases resulting from gain-of-function mutations in the NLRP3 gene.
Joanna Nadaj   +9 more
doaj   +1 more source

Interleukin inhibitors and the associated risk of candidiasis

open access: yesFrontiers in Immunology
Interleukins (ILs) are vital in regulating the immune system, enabling to combat fungal diseases like candidiasis effectively. Their inhibition may cause enhanced susceptibility to infection.
Sabir Khan   +19 more
doaj   +1 more source

Cardiac magnetic resonance imaging paralleled recurrent pericarditis clinical response to rilonacept treatment over 18 months: a RHAPSODY subgroup analysis [PDF]

open access: yes
Cardiac magnetic resonance imaging paralleled recurrent pericarditis clinical response to rilonacept treatment over 18 months: a RHAPSODY subgroup analysis Authors: Paul C.
Curtis, Allison   +13 more
core  

Home - About - Disclaimer - Privacy